Is it Wise to Invest in Eli Lilly (LLY)?

Saturna Capital, an investment management firm, published its “Amana Funds” fourth-quarter 2021 investor letter – a copy of which can be downloaded here. For the fourth quarter of 2021, the Amana Income Fund Investor Shares returned 13.76% and the Institutional Shares returned 13.85%. The Amana Growth Fund sprinted to a strong finish in the fourth quarter, wrapping up an outstanding year by any measure. For the three months ended December 31, 2021, the Amana Growth Fund Investor Shares returned 14.41%, significantly outpacing the 6.91% Morningstar “Large Growth” category return, as well as the 11.03% return of the S&P 500. For the 2021 calendar year, Amana Developing World Fund Investor Shares returned 7.31% versus -2.54% for the MSCI Emerging Markets Index. Spare some time to check the fund’s top 5 holdings to have a clue about their top bets for 2022.

Saturna Capital Amana Funds, in its Q4 2021 investor letter, mentioned Eli Lilly and Company (NYSE: LLY) and discussed its stance on the firm. Founded in 1876, Eli Lilly and Company is an Indianapolis, Indiana-based pharmaceutical company with a $247.5 billion market capitalization, and is currently spearheaded by its CEO, David A. Ricks. LLY delivered a -5.90% return since the beginning of the year, while its 12-month returns are up by 26.52%. The stock closed at $259.93 per share on March 08, 2022.

Here is what Saturna Capital Amana Funds has to say about Eli Lilly and Company in its Q4 2021 investor letter:

“Industrials and pharmaceutical companies were among the Amana Income Fund’s strongest performers in the fourth quarter. Industrials and pharmaceutical companies were among the Amana Income Fund’s strongest performers in the fourth quarter. Drug maker Eli Lilly is represented in the 10 Largest Contributors.”

Our calculations show that Eli Lilly and Company (NYSE: LLY) failed to obtain a mark on our list of the 30 Most Popular Stocks Among Hedge Funds. LLY was in 61 hedge fund portfolios at the end of the fourth quarter of 2021, compared to 62 funds in the previous quarter. Eli Lilly and Company (NYSE: LLY) delivered a 6.39% return in the past 3 months.

In August 2021, we also shared another hedge fund’s views on LLY in another article. You can find other letters from hedge funds and prominent investors on our hedge fund investor letters 2021 Q4 page.

Disclosure: None. This article is originally published at Insider Monkey.